These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 136473)

  • 1. Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.
    DeLustro F; Argyris BF
    J Immunol; 1976 Dec; 117(6):2073-80. PubMed ID: 136473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response.
    Fitch FW; Engers HD; Cerottini JC; Bruner KT
    J Immunol; 1976 Mar; 116(3):716-23. PubMed ID: 56399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.
    Kamo I; Patel C; Kateley J; Friedman H
    J Immunol; 1975 Jun; 114(6):1749-56. PubMed ID: 805176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.
    Hirano T; Nordin AA
    J Immunol; 1976 Dec; 117(6):2226-32. PubMed ID: 62810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures.
    Hirano T; Nordin AA
    J Immunol; 1976 Apr; 116(4):1115-22. PubMed ID: 130426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I. Characterization of suppressor cells of the mixed lymphocyte reaction.
    Weigensberg M; Morecki S; Weiss L; Fuks Z; Slavin S
    J Immunol; 1984 Feb; 132(2):971-8. PubMed ID: 6140288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.
    Peavy DL; Pierce CW
    J Immunol; 1975 Dec; 115(6):1515-20. PubMed ID: 1184965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of suppressor cells by syngeneic tumor transplants in mice.
    Argyris BF
    Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigens.
    Huston DP; Jenkins RN; Gresens SE; Smith R; Rich RR
    J Immunol; 1985 Apr; 134(4):2198-204. PubMed ID: 3156180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cell subpopulations in pregnancy. I. Evidence for suppressive activity of the early phase of MLR.
    Chaouat G; Voisin GA
    J Immunol; 1979 Apr; 122(4):1383-8. PubMed ID: 156216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.